相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic implications of microvascular complications in patients with diabetes and heart failure with reduced ejection fraction
Kershaw V. Patel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
CELF1 Mediates Connexin 43 mRNA Degradation in Dilated Cardiomyopathy
Kuei-Ting Chang et al.
CIRCULATION RESEARCH (2017)
Ischemia and No Obstructive Coronary Artery Disease (INOCA) Developing Evidence-Based Therapies and Research Agenda for the Next Decade
C. Noel Bairey Merz et al.
CIRCULATION (2017)
Growing Evidence Linking Microvascular Dysfunction With Heart Failure With Preserved Ejection Fraction
Gregory Giamouzis et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction
Selma F. Mohammed et al.
CIRCULATION (2015)
VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level
Tania Arcondeguy et al.
NUCLEIC ACIDS RESEARCH (2013)
Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF
Hisato Nako et al.
HYPERTENSION RESEARCH (2012)
MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development
Auinash Kalsotra et al.
GENES & DEVELOPMENT (2010)
Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1
Misha Koshelev et al.
HUMAN MOLECULAR GENETICS (2010)
The Cav3.2 T-Type Ca2+ Channel Is Required for Pressure Overload-Induced Cardiac Hypertrophy in Mice
Chien-Sung Chiang et al.
CIRCULATION RESEARCH (2009)
PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1
Guey-Shin Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Molecular Mechanisms Underlying the Transition of Cardiac Hypertrophy to Heart Failure
Toru Oka et al.
CIRCULATION JOURNAL (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart
Auinash Kalsotra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J. Harper et al.
NATURE REVIEWS CANCER (2008)
Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart (vol 117, pg 3198, 2007)
Joerg Heineke et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart
Joerg Heineke et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Increased steady-state in levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation
N. Muge Kuyumcu-Martinez et al.
MOLECULAR CELL (2007)
Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy
Guey-Shin Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability
T Oka et al.
CIRCULATION RESEARCH (2006)
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
H Takahashi et al.
CLINICAL SCIENCE (2005)
Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies
O Tarnavski et al.
PHYSIOLOGICAL GENOMICS (2004)
Selective downregulation of VEGF-A165, VEGF-R1, and decreased capillary density in patients with dilative but not ischemic cardiomyopathy
D Abraham et al.
CIRCULATION RESEARCH (2000)
The VEGF splice variants: Properties, receptors, and usage for the treatment of ischemic diseases
Z Poltorak et al.
HERZ (2000)
分享论文
